Williams Jones Wealth Management, LLC. - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 47 filers reported holding ONCOCYTE CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Williams Jones Wealth Management, LLC. ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q1 2023$5,316
+10.4%
15,0000.0%0.00%
Q4 2022$4,814
-56.2%
15,0000.0%0.00%
Q3 2022$11,000
-15.4%
15,0000.0%0.00%
Q2 2022$13,000
-40.9%
15,0000.0%0.00%
Q1 2022$22,000
-33.3%
15,0000.0%0.00%
Q4 2021$33,000
-57.7%
15,0000.0%0.00%
-100.0%
Q1 2021$78,000
+116.7%
15,0000.0%0.00%0.0%
Q4 2020$36,000
+71.4%
15,0000.0%0.00%
Q3 2020$21,000
-27.6%
15,0000.0%0.00%
-100.0%
Q2 2020$29,000
-21.6%
15,0000.0%0.00%0.0%
Q1 2020$37,000
+8.8%
15,0000.0%0.00%0.0%
Q4 2019$34,000
+6.2%
15,0000.0%0.00%0.0%
Q3 2019$32,00015,0000.00%
Other shareholders
ONCOCYTE CORP shareholders Q2 2023
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,056,680$15,895,0002.92%
IHT Wealth Management, LLC 200$386,0000.19%
Family Management Corp 22,570$117,0000.08%
Artal Group S.A. 150,000$780,0000.01%
Destination Wealth Management 29,656$154,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 145,000$754,0000.01%
Advisor Group, Inc. 102$1,0000.00%
FIFTH THIRD BANCORP 210$1,0000.00%
HUNTINGTON NATIONAL BANK 10$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 2,233$12,0000.00%
View complete list of ONCOCYTE CORP shareholders